학술논문
HEMOLYTIC ANEMIA: A RARE SIDE EFFECT OF POST INTRAVENOUS IMMUNOGLOBULIN TREATMENT IN KAWASAKI DISEASE PATIENTS.
Document Type
Article
Author
Source
Annals of Allergy, Asthma & Immunology; November 2023, Vol. 131 Issue: 5, Number 5 Supplement 1 pS120-S120, 1p
Subject
Language
ISSN
10811206
Abstract
Autoimmune Hemolytic Anemia has been associated as a serious side effect of Intravenous Immunoglobulin (IVIG) administration in pediatric population, rarely described, and underrecognized. We encountered three unique cases of children under two years old diagnosed with Kawasaki Disease and treated with one dose of (2g/kg) IVIG over a 8-12 hrs infusion, that developed autoimmune hemolytic anemia.